Xeloda monotherapy

Related by string. * : capecitabine Xeloda ® . Xeloda capecitabine . capecitabine Xeloda R . oral capecitabine Xeloda . capecitabine Xeloda . Roche Xeloda . chemotherapy Xeloda . oral Xeloda / Monotherapy : methotrexate monotherapy . Lucentis monotherapy . REMICADE monotherapy . artemisinin monotherapy . infliximab monotherapy . Tysabri monotherapy . metformin monotherapy * *

Related by context. Frequent words. (Click for all words.) 60 laboratory abnormalities 60 peripheral edema 59 leukopenia 58 arthralgia 57 nausea fatigue 57 acneform rash 57 sensory neuropathy 57 treatment emergent adverse 57 neurologic symptoms 56 diarrhea nausea vomiting 56 nasopharyngitis 56 cerebrovascular events 55 discontinuations due 55 lymphopenia 55 TYSABRI treated 54 muscle spasticity 54 nonfatal stroke 54 Peripheral neuropathy 54 Asymptomatic 54 lower limb amputations 53 lower limb amputation 53 % CI #.#-#.# [007] 53 venous thromboembolic events 53 prolactin levels 53 QTc prolongation 53 fatigue nausea 52 arthritis gout 52 TAXUS p value 52 Thrombocytopenia 52 recurrent seizures 52 endophthalmitis 52 spinal cord compression 52 events AEs 52 haemorrhagic stroke 51 events SAEs 51 Neutropenia 51 Ulcerative colitis 51 Hip fractures 51 & s2 = 51 corticosteroid therapy 51 hemiplegia 51 metabolic acidosis 51 bone marrow suppression 51 somatic symptoms 51 ulcerations 51 daytime drowsiness 51 blindness deafness 50 Obstructive sleep apnea 50 myocardial infarction stroke 50 estrogen deficiency 50 thromboembolic 50 g trans fats 50 receiving VELCADE 50 neuropathies 50 hypoglycemic events 50 contractures 50 pericardial effusion 50 menstrual irregularities 50 Expanded Disability Status 50 akathisia 50 revascularization procedures 50 Urinary tract infections 49 generalized anxiety 49 thromboembolic events 49 morbidity mortality 49 femur fracture 49 depression irritability 49 0 document.write 49 Neuropathic pain 49 nonmalignant 49 Allergic rhinitis 49 radiation dermatitis 49 DJ DGAP PVR Publication 49 Lactic acidosis 49 spine fractures 49 lumiracoxib 49 vertebral fractures 49 hypomagnesemia 49 febrile neutropenia 48 peginterferon alfa 48 headache nausea 48 CI #.#-#.# [002] 48 nausea headache 48 varus 48 % #gt 48 hyperbilirubinemia 48 recurrent stroke 48 spleen liver 48 blood clotting disorder 48 contracture 48 bone deformities 48 haemorrhagic 48 Varicose veins 48 brain lesions 48 Recurrence 48 osteo arthritis 48 renal toxicity 48 mucositis 48 patients receiving ERBITUX 48 carotid stenosis 48 f h

Back to home page